# TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)

> **NCT00413205** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 491 (actual)

## Conditions studied

- Emphysema

## Interventions

- **DRUG:** Placebo
- **DRUG:** RAR Gamma

## Key facts

- **NCT ID:** NCT00413205
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 491 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413205, "TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00413205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*